MÖLNDAL, Sweden, Oct. 30, 2023 /PRNewswire/ — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company’s OPRA™ Implant system is approved by FDA to be used in a clinical study on below-knee amputations in the US. The clinical study will be important…